Does MEROPENEM ANHYDROUS Cause Agranulocytosis? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Agranulocytosis have been filed in association with MEROPENEM ANHYDROUS (Meropenem). This represents 11.8% of all adverse event reports for MEROPENEM ANHYDROUS.
17
Reports of Agranulocytosis with MEROPENEM ANHYDROUS
11.8%
of all MEROPENEM ANHYDROUS reports
3
Deaths
11
Hospitalizations
How Dangerous Is Agranulocytosis From MEROPENEM ANHYDROUS?
Of the 17 reports, 3 (17.6%) resulted in death, 11 (64.7%) required hospitalization, and 2 (11.8%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
Yes, Agranulocytosis is listed as a known adverse reaction in the official FDA drug label for MEROPENEM ANHYDROUS.
What Other Side Effects Does MEROPENEM ANHYDROUS Cause?
Drug reaction with eosinophilia and systemic symptoms (31)
Cholestasis (16)
Hepatic cytolysis (13)
Toxic epidermal necrolysis (12)
Encephalopathy (8)
Eosinophilia (8)
Neutropenia (7)
Quadriparesis (6)
Rash maculo-papular (6)
Rash morbilliform (6)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which MEROPENEM ANHYDROUS Alternatives Have Lower Agranulocytosis Risk?
MEROPENEM ANHYDROUS vs MESALAMINE
MEROPENEM ANHYDROUS vs MESNA
MEROPENEM ANHYDROUS vs METAMIZOLE
MEROPENEM ANHYDROUS vs METARAMINOL
MEROPENEM ANHYDROUS vs METAXALONE